BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 33292100)

  • 1. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
    Granadillo Rodríguez M; Flath B; Chelico L
    Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases.
    Wong L; Sami A; Chelico L
    Nucleic Acids Res; 2022 Nov; 50(21):12039-12057. PubMed ID: 36444883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
    Gao J; Choudhry H; Cao W
    Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Interaction Map of APOBEC3 Enzyme Family Reveals Deamination-Independent Role in Cellular Function.
    Jang GM; Annan Sudarsan AK; Shayeganmehr A; Prando Munhoz E; Lao R; Gaba A; Granadillo Rodríguez M; Love RP; Polacco BJ; Zhou Y; Krogan NJ; Kaake RM; Chelico L
    Mol Cell Proteomics; 2024 May; 23(5):100755. PubMed ID: 38548018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
    Ito F; Fu Y; Kao SA; Yang H; Chen XS
    J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the APOBEC3 Family Is Associated with a Poor Prognosis and Influences Treatment Response to Raf Inhibitors in Low Grade Glioma.
    Luo C; Wang S; Liao W; Zhang S; Xu N; Xie W; Zhang Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of APOBEC3 mutagenesis in human cancer cells.
    Petljak M; Dananberg A; Chu K; Bergstrom EN; Striepen J; von Morgen P; Chen Y; Shah H; Sale JE; Alexandrov LB; Stratton MR; Maciejowski J
    Nature; 2022 Jul; 607(7920):799-807. PubMed ID: 35859169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOBEC3s: DNA-editing human cytidine deaminases.
    Silvas TV; Schiffer CA
    Protein Sci; 2019 Sep; 28(9):1552-1566. PubMed ID: 31241202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
    Adolph MB; Love RP; Feng Y; Chelico L
    Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?
    Warren CJ; Santiago ML; Pyeon D
    Annu Rev Virol; 2022 Sep; 9(1):375-395. PubMed ID: 35671565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species.
    Auerbach AA; Becker JT; Moraes SN; Moghadasi SA; Duda JM; Salamango DJ; Harris RS
    mSphere; 2022 Dec; 7(6):e0045122. PubMed ID: 36374108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation-induced deoxycytidine deaminase: Structural basis for favoring WRC hot motif specificities unique among APOBEC family members.
    Pham P; Afif SA; Shimoda M; Maeda K; Sakaguchi N; Pedersen LC; Goodman MF
    DNA Repair (Amst); 2017 Jun; 54():8-12. PubMed ID: 28388461
    [No Abstract]   [Full Text] [Related]  

  • 14. APOBEC: A molecular driver in cervical cancer pathogenesis.
    Revathidevi S; Murugan AK; Nakaoka H; Inoue I; Munirajan AK
    Cancer Lett; 2021 Jan; 496():104-116. PubMed ID: 33038491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC Enzymes as Targets for Virus and Cancer Therapy.
    Olson ME; Harris RS; Harki DA
    Cell Chem Biol; 2018 Jan; 25(1):36-49. PubMed ID: 29153851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
    Petljak M; Green AM; Maciejowski J; Weitzman MD
    Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.
    Smith HC
    RNA Biol; 2017 Sep; 14(9):1153-1165. PubMed ID: 27869537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
    Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
    Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical Basis of APOBEC3 Deoxycytidine Deaminase Activity on Diverse DNA Substrates.
    Adolph MB; Love RP; Chelico L
    ACS Infect Dis; 2018 Mar; 4(3):224-238. PubMed ID: 29347817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.
    Lackey L; Law EK; Brown WL; Harris RS
    Cell Cycle; 2013 Mar; 12(5):762-72. PubMed ID: 23388464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.